Dongsheng Wu, Shiyou Wei. "Evaluating activation of MAPK signaling as a potential mechanism of acquired resistance to lorlatinib in ALK-rearranged lung cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e20000